Previous Article | Next Article 
Infect Immun, May 1998, p. 2230-2236, Vol. 66, No. 5
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Isolation of the Third Capsule-Associated Gene,
CAP60, Required for Virulence in Cryptococcus
neoformans
Y. C.
Chang and
K. J.
Kwon-Chung*
Laboratory of Clinical Investigation,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, Bethesda, Maryland 20892
Received 14 November 1997/Returned for modification 17 December
1997/Accepted 18 February 1998
 |
ABSTRACT |
A polysaccharide capsule is one of the most important virulence
factors for the pathogenic fungus Cryptococcus neoformans. We previously characterized two capsule-associated genes,
CAP59 and CAP64. To further dissect the
molecular mechanism of capsule synthesis, 16 acapsular mutants induced
by 4-nitroquinoline-1-oxide were obtained. The acapsular phenotype of
one of these mutants was complemented. The cloned gene was designated
CAP60, and deletion of this newly described
capsule-associated gene resulted in an acapsular phenotype. The
proposed 67-kDa Cap60p contains 592 amino acids and appears to have a
putative transmembrane domain close to the N terminus. DNA sequence
analysis revealed that CAP60 has similarity to
CAP59 at the center portion of its coding regions. Contour-clamped homogeneous electric field blot analysis suggested that
these two genes are on the same chromosome. CAP60 and
CAP59, however, could not be functionally substituted for
each other by direct complementation or by domain swap experiments. In
addition, CAP60 is closely linked to a gene which is
similar to a cellulose growth-specific gene of Agaricus
bisporus, CEL1. Immunogold electron microscopy
studies of the epitope-tagged CAP60 gene revealed that Cap60p was primarily localized to the nuclear membrane. Animal model
studies indicated that CAP60 is essential for virulence. Thus, CAP60 is required for both capsule formation and
virulence.
 |
INTRODUCTION |
Cryptococcus neoformans
is a pathogenic yeast which produces a thick extracellular
polysaccharide capsule. The polysaccharide capsule is a well-recognized
virulence factor of C. neoformans (14, 18).
Classical recombination analysis has identified several different
genetic loci controlling capsule formation (22). Recently,
we complemented two previously identified acapsular mutants and cloned
two genes, CAP59 and CAP64 (6, 7).
Capsule formation requires functional copies of both genes; deletion of either gene results in an acapsular phenotype. CAP59 and
CAP64 are not essential genes, and deletion of either one
does not interfere with the growth of C. neoformans.
However, both genes are essential for virulence in mice, because
acapsular strains resulting from gene deletion are unable to produce
fatal infections or multiply in vivo and complementation of the
acapsular phenotype restores virulence.
Although CAP59 and CAP64 are essential for
capsule formation, the biochemical functions of these two genes are not
clear. Analysis of DNA sequences did not reveal their functions.
Functional analysis of the Cap59p protein, as determined by expressing
different regions of CAP59 under control of the C. neoformans GAL7 promoter, indicates that the putative
transmembrane domain at the N terminus of Cap59p is required for its
ability to complement the cap59 acapsular phenotype
(8). In addition, the glycine residue in the center of the
gene is important for CAP59 function, because a missense
mutation at the Gly324 residue abolished complementation by the
GAL7 fusion construct (8).
The CAP59 and CAP64 loci were previously reported
to be closely linked (22), but further studies by molecular
as well as classical recombinational analysis revealed that they are
actually on separate chromosomes: CAP59 is on chromosome I
and CAP64 is on chromosome III (7). Several
unique features of these two genes have been reported. Both are closely
linked to convergently transcribed genes. CAP59 is closely
linked to the gene encoding the putative mitochondrial ribosomal L27
protein, and CAP64 is linked to the putative proteasome
subunit gene, PRE1. In both cases the distance between the
linked genes is under 30 bp. CAP59 contains six introns, and
CAP64 contains eight introns.
To further dissect the molecular mechanisms of capsule formation, we
isolated more acapsular strains by mutagenesis. In this paper, we
describe the isolation and characterization of another capsule-associated gene, CAP60, and our attempt to
immunolocalize its product.
 |
MATERIALS AND METHODS |
Strains and media.
C. neoformans var.
neoformans serotype D wild-type isolates B-3501 (
mating
type) and B-3502 (a mating type) have been described before
(16). B-4500 is a wild-type congenic strain of B-4476
(17). R748 is a capsule-deficient mutant received from
E. S. Jacobson as strain 326 (22). The LP1 strain is an F4 progeny of an ade2 strain, red13B
(7). B-4500FO2 is a ura5 auxotroph of B-4500.
Strain cap60-17 is an acapsular mutant generated by mutagenesis.
cap60-17FO7, which was used for transformations, is a ura5
auxotroph of cap60-17 and was isolated according to the method
described previously (19). All strains were maintained on
YEPD (1% yeast extract, 2% Bacto Peptone, and 2% dextrose). Minimal
medium (YNB) contained 6.7 g of yeast nitrogen base without amino
acids (Difco) and 20 g of glucose per liter. 5-Fluoroorotic acid
(5-FOA) medium contained 6.7 g of yeast nitrogen base (Difco), 1 g of 5-FOA, 50 mg of uracil, and 20 g of glucose per liter.
Transformation of C. neoformans.
The electroporation
method described by Edman and Kwon-Chung was used to transform C. neoformans (12). TYCC111 and CIP3 were stable
encapsulated and acapsular transformants, respectively, of cap60-17FO7
which were selected among Ura5+ stable transformants after
three transfers on YEPD medium.
Isolation of capsule-deficient strains.
The log-phase
culture of B-4500 was treated with 4-nitroquinoline-1-oxide at 37°C
for 30 min to achieve 90% killing. The mutagenized cells were plated
on YEPD medium. Yeast cells from colonies with abnormal morphology were
examined for the presence of capsules by microscopic examination of
India ink slide preparations. Antibody screening of colony blots was
performed by standard methods. In brief, a nitrocellulose filter was
laid on the plate for 1 min and air dried for 5 min. The filter was
washed with a solution containing 50 mM Tris (pH 7.5), 200 mM NaCl,
0.1% Tween 20, and 5% nonfat dry milk; incubated with anti-capsule
rabbit antibody; reacted with horseradish peroxidase-conjugated goat
anti-rabbit immunoglobulin G (IgG) secondary antibody (Bio-Rad
Laboratories, Hercules, Calif.); and treated with 4-chloro-1-naphthol
and hydrogen peroxide. The reaction was stopped with water.
Preparation and analysis of nucleic acid and proteins.
Genomic DNA isolation and analysis were performed as described
previously (6). Random hexamer priming was used to label the
DNA probes to specific activities of >108 dpm/µg
(13). DNA sequencing was performed by the dideoxy-mediated chain termination method with a Sequenase version 2.0 kit (U.S. Biochemicals, Cleveland, Ohio). Programs of the University of Wisconsin
Genetics Computer Group (Madison) were used for analysis of nucleic
acid sequences (10).
Total proteins were isolated by glass bead disruption of yeast cells in
20 mM Tris (pH 8.0), 10 mM MgCl2, 1 mM EDTA, 5% glycerol, 1 mM dithiothreitol, 100 mM KCl, 1 mM phenylmethylsulfonyl fluoride, and other proteinase inhibitors. The protein extracts were cleared by
centrifugation in a microcentrifuge at 4°C for 30 min, 30 µg of
protein was loaded onto a sodium dodecyl sulfate-8% polyacrylamide gel, and the separated proteins were transferred to a polyvinylidene fluoride membrane (Millipore, Bedford, Mass.). The membrane was incubated with anti-hemagglutinin (HA) monoclonal antibody (BAbCO, Richmond, Calif.) followed by secondary antibody, obtained from the
Western-Star chemiluminescent detection system (TROPIX, Bedford, Mass.)
and used as suggested by the manufacturer.
Construction of plasmids.
The URA5-containing
plasmid, pCIP3, and the ADE2-containing plasmid, pADE
Apa,
were received from J. C. Edman (6). To rescue free
plasmids from C. neoformans, the genomic DNA from the
transformants was digested with NotI, ligated, and
transformed into Escherichia coli. For PCR cloning,
approximately 50 ng of genomic DNA from the encapsulated transformants
of cap60-17FO7 was used along with the primer set flanking the cloning
site of pCnTEL1. The PCR was performed with Taqplus DNA
polymerase (Stratagene, La Jolla, Calif.) in a 50-µl total reaction
volume and allowed to run for 25 cycles of 94°C for 40 s, 60°C
for 1 min, and 72°C for 4 min per cycle. To construct pYCC109, the
4.8-kb PCR product was gel isolated (GeneClean II; Bio 101, Vista,
Calif.) and cloned into pCIP3. The plasmids pYCC110, pYCC111, pYCC112,
pYCC113, pYCC114, and pYCC115 were subclones of pYCC109 in pCIP3 (Fig.
1).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
Map of CAP60. (A) Restriction enzyme map.
Overlapping subclones of pYCC107 were diagrammed. pYCC120 is the
reconstituted genomic clone. Plasmids were transformed into
cap60-17FO7, and the capsular phenotypes of the resulting transformants
were as indicated (+, present; , absent). Open and hatched boxes
represent the coding regions of CEL1 and CAP60,
respectively. B, BamHI; D, NdeI; N,
NcoI; P, PstI; S, SmaI; X,
XhoI; V, EcoRV; Xb, XbaI. (B)
Transcriptional direction of CAP60 and CEL1.
Arrows indicate the direction of transcription. Triangles represent
introns.
|
|
To construct a partial library, genomic DNA of B-4500 was digested with
XhoI and fractionated on a 0.8% agarose gel. The region
from 4 to 6 kb was gel isolated and ligated to the pBluescript
vector.
The library was screened with the 4.8-kb PCR fragment.
Positive clones
were isolated, and a clone containing an additional
2.4 kb of the
CAP60 3' flanking region was reconstructed into
the pCIP3
vector (pYCC120 [Fig.
1]). The
ApaI/
EcoRI
fragment of
pADE

Apa, which contained the functional
ADE2
gene, was cloned
into the
SmaI site of pBluescript to give
pYCC76. The 1.5-kb
NcoI/
BamHI
region of pYCC120
was replaced with the 3.0-kb
BamHI/
EcoRV fragment
of the
ADE2 gene from pYCC76 to give pYCC122.
For the domain swap experiment, the 0.8-kb
PstI/
AatII fragment of pYCC14 plasmid containing
CAP59 was cloned into the
BssHII/
PpuMI
site of pYCC111 to give pYCC195.
Plasmid pYCC136 was a subclone of pYCC111 containing the carboxyl
terminus of Cap60p. The HA epitope (YPYDYPDYA) (
28) was
inserted in frame at the carboxyl terminus of Cap60p by PCR
amplification
of pYCC136 as described previously (
23). The
resulting plasmid
(pYCC142) was sequenced to confirm that no errors had
been introduced
during amplification. The 3' end of
CAP60 in
pYCC111 was replaced
with the tagged fragment in pYCC142 to generate
pYCC145. GETP1
contained three tandem copies of HA pYCC202, as
developed by M.
Tyers and B. Futcher. The
BstXI/
XbaI fragment of GETP1 was cloned
into
pYCC142 to give pYCC198, and the 3' end of
CAP60 in pYCC111
was replaced with the three-HA-tagged fragment in pYCC198 to generate
pYCC202.
Protein localization.
The immunofluorescence method used was
that described by Pringle et al. (20) with modifications.
Cells were fixed in 4% formaldehyde in 50 mM potassium phosphate (pH
6.5) for 2 h at room temperature, washed with 20 mM sodium
citrate-1 M sorbitol at pH 5.8, and digested with 10 mg of mureinase
(U.S. Biochemicals) per ml in the same buffer at 37°C for 1 h.
The fixed cells were attached to polylysine-treated slides and were
incubated at room temperature for 1 h with anti-HA antibody in
phosphate-buffered saline containing 1 mg of bovine serum albumin per
ml. After treatment with fluorescein-conjugated anti-IgG secondary
antibody (Boehringer Mannheim, Indianapolis, Ind.), the slides were
viewed by immunofluorescence microscopy.
Postembedding immunolabeling procedures were performed by Science
Application International Corp. (Frederick, Md.) as described
previously (
24). Briefly, the procedures were carried out at
4°C to minimize the loss of proteins during the process. Log-phase
yeast cells grown in minimal medium were fixed in an equal volume
of
8% formaldehyde and 0.2% glutaraldehyde solution overnight
at 4°C.
The cells were rinsed, dehydrated in graded ethanol, infiltrated
in LR
Gold resin (Ted Pella, Inc., Redding, Calif.), and allowed
to
polymerize under UV light in a

20°C cryochamber (Ted Pella,
Inc.).
Ultrathin sections (50 to 60 nm) were mounted on a 300-mesh
nickel grid
with a Formvar film. Sections of the grid were blocked
with normal goat
serum and incubated with anti-HA monoclonal antibody
(BAbCO) diluted
1:20 and a 1:100 dilution of 15-nm-diameter colloidal
gold-conjugated
goat anti-mouse IgG secondary antibody (Amersham
Corp., Arlington
Heights, Ill.). The thin sections were counterstained
with uranyl
acetate and lead citrate and observed with an electron
microscope
(Hitachi H-7000) operated at 75 kV.
Virulence study.
Female BALB/c mice (20 g) were injected in
the tail veins with each yeast strain as described previously
(6), and the mortality was monitored.
Nucleotide sequence accession number.
The GenBank nucleotide
sequence accession numbers for the CAP60 and CEL1
sequences reported in this paper are AF030696 and AF030695,
respectively.
 |
RESULTS |
Isolation of the CAP60 gene.
Our previous
collections of the acapsular mutants were generated by UV irradiation
or
N-methyl-N'-nitro-N-nitrosoguanidine treatment of B-3501 and B-3502 (15). To generate different
types of acapsular mutants, we mutagenized a wild-type strain, B-4500, with 4-nitroquinoline-1-oxide. About 1.8 × 104
colonies that survived after mutagenesis were screened for rough colony
morphology, and 38 putative acapsular or hypocapsular strains were
obtained. By use of the anti-capsular rabbit antibody, 16 true
acapsular strains were obtained, and each was transformed with plasmids
containing either CAP59 or CAP64 to complement
the acapsular phenotype. Among the 16 strains, 4 were complemented by
CAP59 and 3 were complemented by CAP64.
Of the other nine strains, one, cap60-17FO7, was randomly chosen to
complement the acapsular phenotype by using the B-4500
DNA constructed
in a genomic library of a telomere-based vector
(
7). Several
encapsulated transformants were isolated following
electroporation and
a two-polymer aqueous-phase treatment to enrich
the encapsulated
population (
6). All the transformants contained
free
plasmids as determined by hybridizing undigested genomic
DNAs with
vector sequences (data not shown). These transformants
lost the free
plasmids and became acapsular when they were grown
on nonselective
medium. These results indicated that the free
plasmids contain the DNA
sequence which complements the acapsular
mutation. To rescue the free
plasmids, DNAs from encapsulated
transformants were digested and
transformed into
E. coli. We failed,
however, in several
attempts to rescue the plasmids directly from
the encapsulated
transformants in
E. coli. A PCR approach was
taken by using
primers flanking the cloning site to amplify the
DNA responsible for
complementation. A 4.8-kb PCR product was
obtained, and it was able to
complement the acapsular mutation
of cap60-17FO7 when the DNA was
cloned into a
URA5 vector (pYCC109
[Fig.
1]). The PCR DNA
product not only complemented cap60-17FO7
but also complemented another
three of the nine newly isolated
acapsular mutants. In addition,
pYCC109 also complemented R-748,
which was one of the acapsular mutants
previously identified as
Cap60 by classical genetic analysis
(
22). To conform with the
nomenclature of capsule genes and
in accordance with previous
classical mutation analysis, we designated
this newly isolated
gene
CAP60.
Characterization of CAP60.
The minimal region required
for complementation of cap60-17FO7 in pYCC109 was determined by
overlapping subcloning (Fig. 1), and the smallest clone, pYCC111, was
sequenced. A stable Cap+ transformant of cap60-17FO7
(TYCC111) was obtained, and the capsule size was similar to that of the
wild-type B-4500 as determined by India ink preparation. The cDNA
clones corresponding to the CAP60 gene were isolated, and
the sequence was compared to that of the genomic clone. DNA sequence
analysis revealed that CAP60 contains two introns and the
canonical TATAAA and CAAT sequences upstream of the initiation codon
are absent. The proposed Cap60p protein contains 592 amino acids with a
calculated molecular mass of 67 kDa and appears to contain a putative
transmembrane domain close to the N terminus.
Database searches did not reveal the biochemical function of
CAP60. However,
CAP60 has some sequence
similarity to the
CAP59 gene. The proteins encoded by
CAP60 and
CAP59 have 46% similarity
and 22%
identity, and most of the conserved regions are in the
central portions
(Fig.
2). The
CAP60 gene,
however, could not
complement the mutation of
cap59 and,
likewise,
CAP59 could not
complement the mutation of
cap60. To test if the regions conserved
between Cap60p and
Cap59p are functionally interchangeable, the
coding region for Cap60p
from Arg184 to Trp393 was replaced with
the coding region for Cap59p
from Ile175 to Ile394 (Fig.
2). The
resulting construct, pYCC195, was
not able to complement the mutation
of either
cap60 or
cap59.

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 2.
Alignment of Cap60p and Cap59p. The alignment was
performed with the Bestfit program from the Genetics Computer Group.
Arg184 and Trp393 of Cap60p and Ile175 and Ile394 of Cap59p, which
delimit the regions used in a domain swap experiment, are underlined.
Gly324 (double underlined) is required for Cap59p function. The
vertical lines, colons, and periods between the sequences indicate the
sequence similarity (10).
|
|
Southern analysis of the contour-clamped homogeneous electric field gel
indicated that
CAP60 is located on the chromosome
I + II doublet, which is similar to the location of
CAP59 (Fig.
3). We used a strain, TYCC6, in which the
chromosome I + II doublet
was resolved (
22) and
determined that
CAP60 is located on chromosome
I, just as
CAP59 is (data not shown).

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 3.
Chromosomal location of CAP60. The
chromosomal DNA was separated by contour-clamped homogeneous electric
field gel electrophoresis and stained with ethidium bromide (blots I
and III). The gel-separated chromosomal DNA was transferred to a nylon
membrane and hybridized with a probe of the 4.8-kb PCR fragment of
CAP60 (blot II) or with a probe of CAP59 (blot
IV). B-3501 ( mating type) and B-3502 (a mating type) are
wild-type strains.
|
|
Linkage of CAP60 and CEL1.
During analysis
of the CAP60 locus and its flanking region, we found that
CAP60 is closely linked to a gene which is immediately upstream and is transcribed in the same direction as CAP60
(Fig. 1). This closely linked gene contains six introns and encodes a
putative protein which has a high serine content close to its C
terminus. This putative 40-kDa protein has 46% similarity and 25%
identity to a cellulose growth-specific gene of Agaricus
bisporus (21) (Fig. 4).
The CEL1 gene of A. bisporus encodes a protein that has an architecture resembling those of the multidomain fungal cellulases, although the sequence of its putative catalytic core is not
matched by any other in the protein and nucleic acid databases (1). The function of the putative CEL1 gene in
C. neoformans is not clear. The phenomenon of
CAP60 being clustered with a different gene was also
observed for the other two capsule-associated genes, CAP59
with L27 and CAP64 with PRE1 (7,
8).

View larger version (59K):
[in this window]
[in a new window]
|
FIG. 4.
Alignment of Cel1p. The alignment was performed with the
Bestfit program from the Genetics Computer Group. CN, Cel1p of C. neoformans; AB, Cel1p of A. bisporus. The GenBank
accession number for CEL1 of A. bisporus is
M86356. The vertical lines, colons, and periods between the sequences
indicate the sequence similarity (10).
|
|
Deletion of CAP60 results in the acapsular
phenotype.
Because of the very low frequency of homologous
integration in C. neoformans serotype D strains, a
positive-negative selection method has been designed to enrich for the
homologous integration event (6). This method required a
double crossover at the flanking region of the gene. However, the
largest clone rescued by PCR (pYCC109) contained less than 400 bp
beyond the stop codon of CAP60 (Fig. 1). To obtain the 3'
flanking region of CAP60, we screened an
XhoI-digested partial genomic library. The plasmid pYCC120,
which contains the additional 2.4 kb of the CAP60 3' flanking region, was subsequently constructed and could restore the
capsule of cap60-17FO7 (Fig. 1). To delete the CAP60 gene, the 1.5-kb NcoI/BamHI region of pYCC120 was
replaced by the ADE2 gene (pYCC122). The resulting plasmid
was transformed into an ade2 ura5 strain and plated on 5-FOA
medium. Two Ade2+ Ura5
acapsular
transformants were isolated. Southern blot analysis was carried out to
determine if the acapsular phenotype was derived from a gene
replacement event (Fig. 5). The DNA blot
was first hybridized with a probe of the 4.8-kb PCR product. The 4.2-kb signal in the wild-type, B-4500, changed to a 5.7-kb signal in the
acapsular transformant, TYCC122 (Fig. 5B, blot I). This result suggested an insertion event at the CAP60 locus. The same
blot was hybridized with the 1.5-kb NcoI/BamHI
region of pYCC120, which was deleted in pYCC122. No hybridization
signal was detected in TYCC122, which indicated a deletion event (Fig.
5B, blot II). Finally, the ADE2 gene probe detected a 5.7-kb
band in TYCC122 and confirmed that gene replacement occurred at the
predicted position (Fig. 5B, blot III). In addition, the
greater-than-12-kb signal in TYCC122 represents the native
ADE2. Thus, Southern blot analysis confirmed that the
acapsular phenotype was generated by deletion of CAP60. In
addition, when TYCC122 was transformed with pYCC109, the resulting
transformants produced capsules.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 5.
Deletion of CAP60. (A) Diagram of
CAP60 deletion. Strain LP1 (ade2 ura5 CAP60) was
transformed with the linearized pYCC122 DNA, and cells were selected on
5-FOA medium. Map 1, chromosomal region containing CAP60;
map 2, pYCC122; map 3, deletion of CAP60 resulting from
double crossover. The figure is not drawn to scale for simplicity.
Hatched box, CAP60 coding region. The CEL1 coding
region is represented by the labeled open box. B, BamHI; D,
NdeI; N, NcoI; P, PstI; S,
SmaI; X, XhoI; V, EcoRV; Xb,
XbaI. (B) Southern blot analysis. Genomic DNA of an
acapsular transformant (TYCC122) and a capsule-containing strain
(B-4500) were digested with XbaI. The membrane was
hybridized with the 4.8-kb PCR product (blot I), the 1.5-kb
NcoI/BamHI region of pYCC120 (blot II), or the
entire pYCC76 plasmid, which contains ADE2 (blot III).
|
|
CAP60 is required for virulence.
The relationship
of virulence and the presence of a capsule has been well established.
We anticipated that the acapsular strain created by deletion of
CAP60 would be avirulent and that complementation of the
acapsular phenotype of cap60 should restore virulence. Animal studies were done to confirm this hypothesis (Fig.
6). The wild-type encapsulated strain
(B-4500) and the Cap+ transformant of cap60-17FO7 (TYCC111)
caused fatal infections in 100% of inoculated mice within 75 days,
although death occurred earlier in mice that received B-4500. The
reduction of virulence could have been due to ectopic integration of
plasmids in TYCC111, as was the case in studies reported previously
(7). Surprisingly, two of the eight mice which received the
acapsular transformant of cap60-17FO7 carrying only vector sequence
(CIP3) died after 75 to 100 days. Yeast cultures recovered from the
brains of these dead mice all produced abundant capsules. Therefore,
the mortality in the mice that received CIP3 was due to reversion in
the capsule phenotype of the mutant. The virulence of the
cap60 deletion mutant (TYCC122) was also compared with the
virulence of the isogenic encapsulated strain (B-4500FO2) (Fig. 6B).
All mice challenged with B-4500FO2 died within 53 days, whereas the
cap60 deletion mutant (TYCC122) failed to produce fatal
infection and mice injected with it remained healthy for more than 100 days postinoculation. Thus, these results confirmed that the
CAP60 gene is required for C. neoformans to
produce fatal infection in mice.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 6.
Virulence test. Groups of eight mice were injected with
about 106 viable cells and monitored to determine
mortality. (A) Results for TYCC111, a stable Cap+
transformant of cap60-17FO7; CIP3, a stable Cap
transformant of cap60-17FO7 harboring only the vector sequence; and
B-4500, a wild-type strain. P was <0.0004 for the
comparison of CIP3 to TYCC111 and B-4500 (Kaplan-Meier analysis). (B)
Results for B-4500FO2, a CAP60 ura5 auxotroph, and TYCC122,
a cap60 deletion mutant and ura5 auxotroph.
P was <0.0001 for the comparison of TYCC122 to B-4500FO2
(Kaplan-Meier analysis).
|
|
Localization of Cap60p.
We have employed peptide
epitope-tagging methods to identify the cellular location of the
CAP60 gene products. The nine-amino-acid epitope of the
influenza HA protein (28) was inserted at the carboxy
terminus of Cap60p (pYCC145). The resulting plasmid was able to
complement the acapsular phenotype of TYCC122. Total proteins were
extracted and analyzed by immunoblotting. The size of the protein
detected by anti-HA antibody corroborated the predicted molecular
weight (Fig. 7A). Immunofluorescence
microscopy was used to visualize the HA-tagged Cap60p fusion proteins,
but the intensity of fluorescence was not high enough to define
the location of Cap60p. A different plasmid, pYCC202, which
contained three copies of HA at the C terminus of Cap60p, was
constructed and was able to complement the cap60 mutation.
The encapsulated transformant containing pYCC202 (TYCC202)
produced a protein of the expected size for HA-tagged Cap60p (Fig. 7A).
However, the degree of intensity in fluorescence was nearly the same as
in TYCC122. Immunogold electron microscopy (EM) was chosen to determine
the location of Cap60p. The immunogold labeling appeared to be on the
nuclear membrane of TYCC202 (Fig. 7B). Little or no labeling was
observed in other places. Control samples without anti-HA antibody
showed no labeling. The freeze substitution technique was also used in immunogold EM, and similar results were observed (data not shown).

View larger version (136K):
[in this window]
[in a new window]
|
FIG. 7.
Localization of Cap60p. (A) Immunoblot analysis. Yeast
cells were grown in YNB, and total protein extracts were analyzed by
sodium dodecyl sulfate-8% polyacrylamide gel electrophoresis and
incubated with anti-HA antibody and the Western-Star chemiluminescent
detection system. B-4500 is a wild-type strain; TYCC145 is an
encapsulated transformant containing a plasmid with a single HA-tagged
CAP60; and TYCC202 is an encapsulated transformant
containing a plasmid with a three-HA-tagged CAP60. (B)
Electron micrograph of TYCC202. The yeast cells grown in YNB were fixed
in equal volumes of 8% formaldehyde and 0.2% glutaraldehyde.
Ultrathin sections (50 to 60 nm) were incubated with anti-HA serum and
with 15-nm-diameter colloidal gold-conjugated goat anti-mouse IgG
secondary antibody. The thin sections were counterstained with uranyl
acetate and lead citrate. The antibodies are associated with the
nuclear envelope (arrows). The picture shown is representative of many
sections. Magnification, ×3,400.
|
|
 |
DISCUSSION |
We have created a new collection of capsule-deficient mutants with
4-nitroquinoline-1-oxide and isolated a new gene, CAP60. Deletion of CAP60 resulted in an acapsular phenotype, and
complementation of the mutation restored the capsule. These data show
that CAP60 is required for capsule formation.
CAP60 is located on the same chromosome as CAP59.
Like the clustering of genes in loci of CAP59 and
CAP64, CAP60 is closely linked to
CEL1, which is similar to a cellulose growth-specific gene
of A. bisporus. The results of animal model studies
confirmed that a capsule is required for C. neoformans to
produce fatal infection in mice. Thus, CAP60, like
CAP59 and CAP64, is required for capsule
formation and virulence.
Although similarity exists between Cap59p and Cap60p, the gene products
cannot functionally substitute for each other by direct complementation
or by domain swap experiments. Both Cap59p and Cap60p contain putative
transmembrane domains. The one in Cap59p appears to be a signal
peptide, which suggests that Cap59p may be secreted, whereas the one in
Cap60p is more like a type II transmembrane domain. The possibility of
a membrane localization of Cap60p is strengthened by the result of
immunogold EM, which localized Cap60p to the nuclear membrane. One
potential caveat of the HA epitope-tagging experiment is that insertion
of the HA epitope could affect cellular localization, although the
resulting construct complemented the acapsular phenotype. The quality
of the immunogold EM picture is inferior to those of other fungi which
are easy to handle. The cristae of mitochondria were not distinct, and
membranes of various organelles appeared to have been disrupted.
However, the agreement of the results from many sections of freeze
substitution and regular immunogold EM methods strengthened the
possibility that the immunogold particle is associated primarily with
the nuclear membrane. The reasons for the technical difficulties
encountered in the immunogold EM and immunofluorescence methods with
C. neoformans are unclear. Difficulties in preservation of
cytoplasmic organelles in immunogold EM studies with C. neoformans have also been encountered by other workers
(27). Different approaches are needed to explain these
difficulties.
The failure experienced in rescuing free plasmids directly from
encapsulated transformants of cap60-17FO7 is not uncommon with C. neoformans. In some instances, the modification of the incoming
DNA in the transformants was so drastic that the DNA sequence inserted
in the cloning site of the telomere vector could not be amplified by
use of PCR primers that flank the cloning site (unpublished data). The
genomic plasmid library was constructed in a pCnTEL1 vector, which
contains telomeres to increase the transformation frequency
(11). The telomeres, however, do not prevent the
modification of incoming DNA in the transformation of C. neoformans. A vector that can provide more stability may be
required to circumvent this problem. Recent isolation of a 1.2-kb DNA
fragment from a minichromosome (26) may provide more vector stability for transformation in C. neoformans
(26a). Whether this DNA fragment can be used in library
construction and prevent the unwanted modifications needs to be tested.
Among the 16 newly isolated acapsular mutants, the acapsular phenotype
of 4 strains could be complemented by CAP59, 3 by
CAP64, and 4 by CAP60. Thus, close to two-thirds
of the easily identifiable acapsular mutants contain mutations which
can be complemented by one of the three cloned genes. Although the
steps involved in the biosynthetic pathway of capsule formation have
not been elucidated, the pathway may involve only a few genes which can dramatically affect the process and result in a clear morphological abnormality
acapsular phenotype. In addition to the truly acapsular mutants, we also obtained 22 hypocapsular mutants. These mutants have a
reduced capsule size and a rough colony surface. The major component of
capsular polysaccharide is glucuronoxylomannan, which is an
-1,3-D-mannopyranose backbone containing a single
-1,2-linked glucuronate residue on one-third of the mannopyranose
residues and varying amounts of xylosylation, depending on the serotype (2-5, 9, 25). It is possible that some of the hypocapsular mutants have defects in the formation of branches or acetylations. Monoclonal antibody or some other reagents which can specifically target the branches or certain acetyl groups may be useful in isolating
the genes responsible for these hypocapsule mutations.
 |
ACKNOWLEDGMENTS |
We thank J. Cutler for his help with the EM studies and critical
review of the manuscript and T. Caesar, L. A. Penoyer, and K. Nagashima for technical assistance.
Part of this work was supported by NIAID grant 5 R01-AI24912 to J. Cutler.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: LCI, NIAID,
Building 10, Room 11C304, National Institutes of Health, Bethesda, MD
20892. Phone: (301) 496-1602. Fax: (301) 480-0050. E-mail:
June_Kwon-chung{at}nih.gov.
Editor: T. R. Kozel
 |
REFERENCES |
| 1.
|
Armesilla, A. L.,
C. F. Thurston, and E. Yague.
1994.
CEL1: a novel cellulose binding protein secreted by Agaricus bisporus during growth on crystalline cellulose.
FEMS Microbiol. Lett.
116:293-299[Medline].
|
| 2.
|
Bhattacharjee, A. K.,
J. E. Bennett, and C. P. Glaudemans.
1984.
Capsular polysaccharides of Cryptococcus neoformans.
Rev. Infect. Dis.
6:619-624[Medline].
|
| 3.
|
Bhattacharjee, A. K.,
K. J. Kwon-Chung, and C. P. Glaudemans.
1979.
On the structure of the capsular polysaccharide from Cryptococcus neoformans serotype C-II.
Mol. Immunol.
16:531-532[Medline].
|
| 4.
|
Bhattacharjee, A. K.,
K. J. Kwon-Chung, and C. P. Glaudemans.
1981.
Capsular polysaccharides from a parent strain and from a possible, mutant strain of Cryptococcus neoformans serotype A.
Carbohydr. Res.
95:237-248[Medline].
|
| 5.
|
Bhattacharjee, A. K.,
K. J. Kwon-Chung, and C. P. Glaudemans.
1992.
The major capsular polysaccharide of Cryptococcus neoformans serotype B.
Carbohydr. Res.
233:271-272[Medline].
|
| 6.
|
Chang, Y. C., and K. J. Kwon-Chung.
1994.
Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence.
Mol. Cell. Biol.
14:4912-4919[Abstract/Free Full Text].
|
| 7.
|
Chang, Y. C.,
L. A. Penoyer, and K. J. Kwon-Chung.
1996.
The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence.
Infect. Immun.
64:1977-1983[Abstract].
|
| 8.
|
Chang, Y. C.,
B. L. Wickes, and K. J. Kwon-Chung.
1995.
Further analysis of the CAP59 locus of Cryptococcus neoformans: structure defined by forced expression and the description of a new ribosomal protein gene.
Gene
167:179-183[Medline].
|
| 9.
|
Cherniak, R.,
E. Reiss, and S. H. Turner.
1982.
A galactoxylomannan antigen of Cryptococcus neoformans serotype A.
Carbohydr. Res.
103:239-250.
|
| 10.
|
Devereux, J.,
P. Haeberli, and O. Smithies.
1984.
A comprehensive set of sequence analysis programs for the VAX.
Nucleic Acids Res.
12:387-395.
|
| 11.
|
Edman, J. C.
1992.
Isolation of telomerelike sequences from Cryptococcus neoformans and their use in high-efficiency transformation.
Mol. Cell. Biol.
12:2777-2783[Abstract/Free Full Text].
|
| 12.
|
Edman, J. C., and K. J. Kwon-Chung.
1990.
Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation.
Mol. Cell. Biol.
10:4538-4544[Abstract/Free Full Text].
|
| 13.
|
Feinberg, A. P., and B. Vogelstein.
1983.
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.
Anal. Biochem.
132:6-13[Medline].
|
| 14.
|
Fromptling, R. A.,
H. K. Shadomy, and E. S. Jacobson.
1982.
Decreased virulence in stable acapsular mutants of Cryptococcus neoformans.
Mycopathologia
79:23-29[Medline].
|
| 15.
|
Jacobson, E. S.,
D. J. Ayers,
A. C. Harrell, and C. C. Nicholas.
1982.
Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans.
J. Bacteriol.
150:1292-1296[Abstract/Free Full Text].
|
| 16.
|
Kwon-Chung, K. J.
1976.
Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans.
Mycologia
68:821-833.
|
| 17.
|
Kwon-Chung, K. J.,
J. C. Edman, and B. L. Wickes.
1992.
Genetic association of mating types and virulence in Cryptococcus neoformans.
Infect. Immun.
60:602-605[Abstract/Free Full Text].
|
| 18.
|
Kwon-Chung, K. J., and J. C. Rhodes.
1986.
Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans.
Infect. Immun.
51:218-223[Abstract/Free Full Text].
|
| 19.
|
Kwon-Chung, K. J.,
A. Varma,
J. C. Edman, and J. E. Bennett.
1992.
Selection of ura5 and ura3 mutants from the two varieties of Cryptococcus neoformans on 5-fluoroorotic acid medium.
J. Med. Vet. Mycol.
30:61-69[Medline].
|
| 20.
|
Pringle, J. R.,
A. E. Adams,
D. G. Drubin, and B. K. Haarer.
1991.
Immunofluorescence methods for yeast.
Methods Enzymol.
194:565-602[Medline].
|
| 21.
|
Raguz, S.,
E. Yague,
D. A. Wood, and C. F. Thurston.
1992.
Isolation and characterization of a cellulose-growth-specific gene from Agaricus bisporus.
Gene
119:183-190[Medline].
|
| 22.
|
Still, C. N., and E. S. Jacobson.
1983.
Recombinational mapping of capsule mutations in Cryptococcus neoformans.
J. Bacteriol.
156:460-462[Abstract/Free Full Text].
|
| 23.
|
Stringer, M. A., and W. E. Timberlake.
1995.
dewA encodes a fungal hydrophobin component of the Aspergillus spore wall.
Mol. Microbiol.
16:33-44[Medline].
|
| 24.
|
Tobin, G. J.,
K. Nagashima, and M. A. Gonda.
1996.
Immunologic and ultrastructural characterization of HIV pseudovirions containing Geg and Env precursor proteins engineered in insect cells.
Methods Companion Methods Enzymol.
10:208-218.
|
| 25.
|
Turner, S. H.,
R. Cherniak,
E. Reiss, and C. K. Kwon.
1992.
Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy.
Carbohydr. Res.
233:205-218[Medline].
|
| 26.
|
Varma, A., and K. J. Kwon-Chung.
1994.
Formation of a minichromosome in Cryptococcus neoformans as a result of electroporative transformation.
Curr. Genet.
26:54-61[Medline].
|
| 26a.
| Varma, A., and K. J. Kwon-Chung. Unpublished
data.
|
| 27.
|
Vartivarian, S. E.,
G. H. Reyes,
E. S. Jacobson,
P. G. James,
R. Cherniak,
V. R. Mumaw, and M. J. Tingler.
1989.
Localization of mannoprotein in Cryptococcus neoformans.
J. Bacteriol.
171:6850-6852[Abstract/Free Full Text].
|
| 28.
|
Wilson, I. A.,
H. L. Niman,
R. A. Houghten,
A. R. Cherenson,
M. L. Connolly, and R. A. Lerner.
1984.
The structure of an antigenic determinant in a protein.
Cell
37:767-778[Medline].
|
Infect Immun, May 1998, p. 2230-2236, Vol. 66, No. 5
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Price, P., Murdoch, D. M., Agarwal, U., Lewin, S. R., Elliott, J. H., French, M. A.
(2009). Immune Restoration Diseases Reflect Diverse Immunopathological Mechanisms. Clin. Microbiol. Rev.
22: 651-663
[Abstract]
[Full Text]
-
Fonseca, F. L., Nimrichter, L., Cordero, R. J. B., Frases, S., Rodrigues, J., Goldman, D. L., Andruszkiewicz, R., Milewski, S., Travassos, L. R., Casadevall, A., Rodrigues, M. L.
(2009). Role for Chitin and Chitooligomers in the Capsular Architecture of Cryptococcus neoformans. Eukaryot Cell
8: 1543-1553
[Abstract]
[Full Text]
-
Grijpstra, J., Gerwig, G. J., Wosten, H., Kamerling, J. P., de Cock, H.
(2009). Production of Extracellular Polysaccharides by CAP Mutants of Cryptococcus neoformans. Eukaryot Cell
8: 1165-1173
[Abstract]
[Full Text]
-
Ko, Y.-J., Yu, Y. M., Kim, G.-B., Lee, G.-W., Maeng, P. J., Kim, S., Floyd, A., Heitman, J., Bahn, Y.-S.
(2009). Remodeling of Global Transcription Patterns of Cryptococcus neoformans Genes Mediated by the Stress-Activated HOG Signaling Pathways. Eukaryot Cell
8: 1197-1217
[Abstract]
[Full Text]
-
Robertson, E. J., Casadevall, A.
(2009). Antibody-Mediated Immobilization of Cryptococcus neoformans Promotes Biofilm Formation. Appl. Environ. Microbiol.
75: 2528-2533
[Abstract]
[Full Text]
-
Botts, M. R., Giles, S. S., Gates, M. A., Kozel, T. R., Hull, C. M.
(2009). Isolation and Characterization of Cryptococcus neoformans Spores Reveal a Critical Role for Capsule Biosynthesis Genes in Spore Biogenesis. Eukaryot Cell
8: 595-605
[Abstract]
[Full Text]
-
Jong, A., Wu, C.-H., Chen, H.-M., Luo, F., Kwon-Chung, K. J., Chang, Y. C., LaMunyon, C. W., Plaas, A., Huang, S.-H.
(2007). Identification and Characterization of CPS1 as a Hyaluronic Acid Synthase Contributing to the Pathogenesis of Cryptococcus neoformans Infection. Eukaryot Cell
6: 1486-1496
[Abstract]
[Full Text]
-
Klutts, J. S., Levery, S. B., Doering, T. L.
(2007). A beta-1,2-Xylosyltransferase from Cryptococcus neoformans Defines a New Family of Glycosyltransferases. J. Biol. Chem.
282: 17890-17899
[Abstract]
[Full Text]
-
Liu, O. W., Kelly, M. J. S., Chow, E. D., Madhani, H. D.
(2007). Parallel {beta}-Helix Proteins Required for Accurate Capsule Polysaccharide Synthesis and Virulence in the Yeast Cryptococcus neoformans. Eukaryot Cell
6: 630-640
[Abstract]
[Full Text]
-
Varma, A., Wu, S., Guo, N., Liao, W., Lu, G., Li, A., Hu, Y., Bulmer, G., Kwon-Chung, K. J.
(2006). Identification of a novel gene, URE2, that functionally complements a urease-negative clinical strain of Cryptococcus neoformans. Microbiology
152: 3723-3731
[Abstract]
[Full Text]
-
Yoneda, A., Doering, T. L.
(2006). A Eukaryotic Capsular Polysaccharide Is Synthesized Intracellularly and Secreted via Exocytosis. Mol. Biol. Cell
17: 5131-5140
[Abstract]
[Full Text]
-
Walton, F. J., Heitman, J., Idnurm, A.
(2006). Conserved Elements of the RAM Signaling Pathway Establish Cell Polarity in the Basidiomycete Cryptococcus neoformans in a Divergent Fashion from Other Fungi. Mol. Biol. Cell
17: 3768-3780
[Abstract]
[Full Text]
-
Clancy, C. J., Nguyen, M. H., Alandoerffer, R., Cheng, S., Iczkowski, K., Richardson, M., Graybill, J. R.
(2006). Cryptococcus neoformans var. grubii isolates recovered from persons with AIDS demonstrate a wide range of virulence during murine meningoencephalitis that correlates with the expression of certain virulence factors.. Microbiology
152: 2247-2255
[Abstract]
[Full Text]
-
Chang, Y. C., Jong, A., Huang, S., Zerfas, P., Kwon-Chung, K. J.
(2006). CPS1, a Homolog of the Streptococcus pneumoniae Type 3 Polysaccharide Synthase Gene, Is Important for the Pathobiology of Cryptococcus neoformans. Infect. Immun.
74: 3930-3938
[Abstract]
[Full Text]
-
Sanguinetti, M., Posteraro, B., La Sorda, M., Torelli, R., Fiori, B., Santangelo, R., Delogu, G., Fadda, G.
(2006). Role of AFR1, an ABC Transporter-Encoding Gene, in the In Vivo Response to Fluconazole and Virulence of Cryptococcus neoformans. Infect. Immun.
74: 1352-1359
[Abstract]
[Full Text]
-
Mylonakis, E., Moreno, R., El Khoury, J. B., Idnurm, A., Heitman, J., Calderwood, S. B., Ausubel, F. M., Diener, A.
(2005). Galleria mellonella as a Model System To Study Cryptococcus neoformans Pathogenesis. Infect. Immun.
73: 3842-3850
[Abstract]
[Full Text]
-
Charlier, C., Chretien, F., Baudrimont, M., Mordelet, E., Lortholary, O., Dromer, F.
(2005). Capsule Structure Changes Associated with Cryptococcus neoformans Crossing of the Blood-Brain Barrier. Am. J. Pathol.
166: 421-432
[Abstract]
[Full Text]
-
Pukkila-Worley, R., Gerrald, Q. D., Kraus, P. R., Boily, M.-J., Davis, M. J., Giles, S. S., Cox, G. M., Heitman, J., Alspaugh, J. A.
(2005). Transcriptional Network of Multiple Capsule and Melanin Genes Governed by the Cryptococcus neoformans Cyclic AMP Cascade. Eukaryot Cell
4: 190-201
[Abstract]
[Full Text]
-
Moyrand, F., Chang, Y. C., Himmelreich, U., Kwon-Chung, K. J., Janbon, G.
(2004). Cas3p Belongs to a Seven-Member Family of Capsule Structure Designer Proteins. Eukaryot Cell
3: 1513-1524
[Abstract]
[Full Text]
-
Moyrand, F., Janbon, G.
(2004). UGD1, Encoding the Cryptococcus neoformans UDP-Glucose Dehydrogenase, Is Essential for Growth at 37{degrees}C and for Capsule Biosynthesis. Eukaryot Cell
3: 1601-1608
[Abstract]
[Full Text]
-
Chang, Y. C., Stins, M. F., McCaffery, M. J., Miller, G. F., Pare, D. R., Dam, T., Paul-Satyasee, M., Kim, K. S., Kwon-Chung, K. J.
(2004). Cryptococcal Yeast Cells Invade the Central Nervous System via Transcellular Penetration of the Blood-Brain Barrier. Infect. Immun.
72: 4985-4995
[Abstract]
[Full Text]
-
Marra, R. E., Huang, J. C., Fung, E., Nielsen, K., Heitman, J., Vilgalys, R., Mitchell, T. G.
(2004). A Genetic Linkage Map of Cryptococcus neoformans variety neoformans Serotype D (Filobasidiella neoformans). Genetics
167: 619-631
[Abstract]
[Full Text]
-
Garcia-Rivera, J., Chang, Y. C., Kwon-Chung, K. J., Casadevall, A.
(2004). Cryptococcus neoformans CAP59 (or Cap59p) Is Involved in the Extracellular Trafficking of Capsular Glucuronoxylomannan. Eukaryot Cell
3: 385-392
[Abstract]
[Full Text]
-
Woyke, T., Berens, M. E., Hoelzinger, D. B., Pettit, G. R., Winkelmann, G., Pettit, R. K.
(2004). Differential Gene Expression in Auristatin PHE-Treated Cryptococcus neoformans. Antimicrob. Agents Chemother.
48: 561-567
[Abstract]
[Full Text]
-
Sommer, U., Liu, H., Doering, T. L.
(2003). An {alpha}-1,3-Mannosyltransferase of Cryptococcus neoformans. J. Biol. Chem.
278: 47724-47730
[Abstract]
[Full Text]
-
Chen, S. H. M., Stins, M. F., Huang, S.-H., Chen, Y. H., Kwon-Chung, K. J., Chang, Y., Kim, K. S., Suzuki, K., Jong, A. Y.
(2003). Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol
52: 961-970
[Abstract]
[Full Text]
-
Bose, I., Reese, A. J., Ory, J. J., Janbon, G., Doering, T. L.
(2003). A Yeast under Cover: the Capsule of Cryptococcus neoformans. Eukaryot Cell
2: 655-663
[Full Text]
-
Chung, S., Mondon, P., Chang, Y. C., Kwon-Chung, K. J.
(2003). Cryptococcus neoformans with a Mutation in the Tetratricopeptide Repeat-Containing Gene, CCN1, Causes Subcutaneous Lesions but Fails To Cause Systemic Infection. Infect. Immun.
71: 1988-1994
[Abstract]
[Full Text]
-
Rude, T. H., Toffaletti, D. L., Cox, G. M., Perfect, J. R.
(2002). Relationship of the Glyoxylate Pathway to the Pathogenesis of Cryptococcus neoformans. Infect. Immun.
70: 5684-5694
[Abstract]
[Full Text]
-
Steen, B. R., Lian, T., Zuyderduyn, S., MacDonald, W. K., Marra, M., Jones, S. J.M., Kronstad, J. W.
(2002). Temperature-Regulated Transcription in the Pathogenic Fungus Cryptococcus neoformans. Genome Res
12: 1386-1400
[Abstract]
[Full Text]
-
Chung, S., Karos, M., Chang, Y. C., Lukszo, J., Wickes, B. L., Kwon-Chung, K. J.
(2002). Molecular Analysis of CPR{alpha}, a MAT{alpha}-Specific Pheromone Receptor Gene of Cryptococcus neoformans. Eukaryot Cell
1: 432-439
[Abstract]
[Full Text]
-
Ma, L. L., Mody, C. H.
(2002). When There Is a Fungus Among Us, What Makes it Virulent?. Am. J. Respir. Cell Mol. Bio.
26: 273-276
[Full Text]
-
Alspaugh, J. A., Pukkila-Worley, R., Harashima, T., Cavallo, L. M., Funnell, D., Cox, G. M., Perfect, J. R., Kronstad, J. W., Heitman, J.
(2002). Adenylyl Cyclase Functions Downstream of the G{alpha} Protein Gpa1 and Controls Mating and Pathogenicity of Cryptococcus neoformans. Eukaryot Cell
1: 75-84
[Abstract]
[Full Text]
-
Petter, R., Kang, B. S., Boekhout, T., Davis, B. J., Kwon-Chung, K. J.
(2001). A survey of heterobasidiomycetous yeasts for the presence of the genes homologous to virulence factors of Filobasidiella neoformans, CNLAC1 and CAP59. Microbiology
147: 2029-2036
[Abstract]
[Full Text]
-
Nelson, R. T., Hua, J., Pryor, B., Lodge, J. K.
(2001). Identification of Virulence Mutants of the Fungal Pathogen Cryptococcus neoformans Using Signature-Tagged Mutagenesis. Genetics
157: 935-947
[Abstract]
[Full Text]
-
Lengeler, K. B., Davidson, R. C., D'souza, C., Harashima, T., Shen, W.-C., Wang, P., Pan, X., Waugh, M., Heitman, J.
(2000). Signal Transduction Cascades Regulating Fungal Development and Virulence. Microbiol. Mol. Biol. Rev.
64: 746-785
[Abstract]
[Full Text]
-
Chang, Y.C., Wickes, B.L., Miller, G.F., Penoyer, L.A., Kwon-Chung, K.J.
(2000). Cryptococcus neoformans STE12{alpha} Regulates Virulence but Is Not Essential for Mating. JEM
191: 871-882
[Abstract]
[Full Text]
-
Cox, G. M., Mukherjee, J., Cole, G. T., Casadevall, A., Perfect, J. R.
(2000). Urease as a Virulence Factor in Experimental Cryptococcosis. Infect. Immun.
68: 443-448
[Abstract]
[Full Text]
-
Cruz, M. C., Sia, R. A. L., Olson, M., Cox, G. M., Heitman, J.
(2000). Comparison of the Roles of Calcineurin in Physiology and Virulence in Serotype D and Serotype A Strains of Cryptococcus neoformans. Infect. Immun.
68: 982-985
[Abstract]
[Full Text]
-
Chang, Y. C., Kwon-Chung, K. J.
(1999). Isolation, Characterization, and Localization of a Capsule-Associated Gene, CAP10, of Cryptococcus neoformans. J. Bacteriol.
181: 5636-5643
[Abstract]
[Full Text]
-
Doering, T. L.
(1999). A Unique alpha -1,3 Mannosyltransferase of the Pathogenic Fungus Cryptococcus neoformans. J. Bacteriol.
181: 5482-5488
[Abstract]
[Full Text]
-
Chang, Y. C., Penoyer, L. A., Kwon-Chung, K. J.
(2001). The second STE12 homologue of Cryptococcus neoformans is MATa-specific and plays an important role in virulence. Proc. Natl. Acad. Sci. USA
98: 3258-3263
[Abstract]
[Full Text]